Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$129,917,324
+$15,175,932 QoQ
Shares Held
7,091,557
0.0% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
11.81%
of 13F equity value
Holder Rank
#11
of 257 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARCH Venture Management, LLC holds $1,092,140,745 across 11 Biotechnology names. ERAS ranks #5 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBLS |
Parabilis Medicines, Inc.
|
6,412,780 | $175,517,788 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
4,540,132 | $155,817,330 | |
| 3 | RAPP |
Rapport Therapeutics, Inc.
|
3,728,738 | $155,376,512 | |
| 4 | SPTX |
Seaport Therapeutics, Inc.
|
6,294,951 | $136,726,335 | |
| 5 | ERAS |
Erasca, Inc.
This page
|
7,091,557 | $129,917,324 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
12,694,163 | $129,353,520 | |
| 7 | MAZE |
Maze Therapeutics, Inc.
|
4,120,053 | $122,942,381 | |
| 8 | LYEL |
Lyell Immunopharma, Inc.
|
3,247,162 | $45,622,626 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129,917,324 | 7,091,557 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $114,741,392 | 7,091,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,126,660 | 11,055,554 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,101,107 | 11,055,554 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,040,553 | 11,055,554 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,146,108 | 11,055,554 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,749,440 | 11,055,554 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,181,662 | 11,055,554 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,091,107 | 11,055,554 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,774,441 | 11,055,554 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $23,548,330 | 11,055,554 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,779,441 | 11,055,554 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,513,329 | 11,055,554 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $33,277,217 | 11,055,554 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $47,649,437 | 11,055,554 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $86,233,321 | 11,055,554 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $61,579,435 | 11,055,554 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $95,077,764 | 11,055,554 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $172,245,531 | 11,055,554 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||